Kayoko Kabaya
Nagoya City University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Kayoko Kabaya.
Acta Oto-laryngologica | 2011
Shinichi Esaki; Fumi Goshima; Hiroshi Kimura; Shuta Ikeda; Sachiyo Katsumi; Kayoko Kabaya; Nobuhiro Watanabe; Motoyuki Hashiba; Yukihiro Nishiyama; Shingo Murakami
Abstract Conclusion. Our herpes simplex virus (HSV) labyrinthitis mouse model suggests that HSV infection induces vestibular neuritis and sudden deafness. Objective: Viral labyrinthitis has been postulated to play a role in vestibular neuritis and sudden deafness. We established a mouse model to investigate the pathogenesis of HSV-induced labyrinthitis. The relationship between HSV infection and apoptosis in the labyrinth was assessed. Methods: HSV types 1 and 2 were inoculated into the middle ear of mice, and the function of the cochlear and vestibular nerves was assessed. Histopathological changes were examined with hematoxylin and eosin staining. Anti-HSV immunohistochemistry staining and TUNEL staining were done to investigate the relationship between HSV-infected cells and apoptotic cells. Results: Hearing loss and vestibular dysfunction were observed in all mice after inoculation of HSV type 1 or 2. In the cochlear duct, columnar epithelial cells in the stria vascularis were infected with HSV, but only a portion of the infected cells underwent apoptosis. In contrast, many uninfected cells in the spiral organ of Corti were apoptotic. Vestibular dysfunction was observed when vestibular ganglion cells were largely infected, but not apoptotic. These findings recapitulate sudden deafness and vestibular neuritis described in patients.
Current Opinion in Otolaryngology & Head and Neck Surgery | 2013
Meiho Nakayama; Kayoko Kabaya
Purpose of reviewSeveral recent reports have described the relation between sleep disorders and inner ear function. There are also many reports that insomnia is observed in Ménières patients. However, the possibility that obstructive sleep apnea syndrome (OSAS) might affect Ménières disease or other neurotological consequences was not noticed, until studies using polysomnography for these patients. Recent findingsOSAS may cause not only vestibular but also auditory dysfunction. Several reports suggest that insufficient supply of blood via the vertebral basilar artery, which supplies the inner ear, may cause hydropic distension of the endolymphatic system and lead to Ménières disease. However, few people noticed that in OSAS this insufficient supply might be exacerbated in the night while patients are sleeping. Even more, we should note that Ménières patients may not only suffer from insomnia, but also that the impaired sleep might be caused by OSAS. SummaryPhysicians routinely prescribe benzodiazepines or other drugs that have hypnotic, muscle relaxing, antianxiety, and anticonvulsant properties for insomnia, but these properties may have the effect of aggravating OSAS symptoms. Continuous positive airway pressure (CPAP) is an effective therapy used worldwide for the treatment of OSAS. CPAP or surgeries for OSAS may also be useful as one aspect of treatment for Ménières disease patients with OSAS.
Acta Oto-laryngologica | 2013
Koichiro Wasano; Sho Kanzaki; Tetsushi Sakashita; Mariko Takahashi; Yasuhiro Inoue; Hideyuki Saito; Masato Fujioka; Takahisa Watabe; Reiko Watanabe; Kishiko Sunami; Shoko Kato; Kayoko Kabaya; Seiichi Shinden; Kaoru Ogawa
Abstract Conclusion: The Japanese version of the Tinnitus Handicap Inventory-12 (THI-12), Tinnitus Rating Scale (TRS), TRS 1-week version (TRSw), Tinnitus Severity Scale (TSS), and TSS 1-week version (TSSw), which were developed in this study, showed high reliability and validity, suggesting their usefulness in clinical practice. Based on the THI severity grades, we propose that the severity grades of THI-12 (draft) are categorized into four groups: 0–4 points, 5–9 points, 10–14 points, and 15–24 points. Objectives: We developed Japanese versions of new questionnaires for evaluating the level of psychological distress and difficulty in activities of daily living due to tinnitus, and performed their psychometric validation to determine the reliability and validity. The THI-12 is an assessment consisting of 12 items, each of which is rated on a 3-point scale that was created by reducing the number of questions from the 25 items of the THI. The TRS, TRSw, TSS, and TSSw, which were self-evaluation questionnaires of tinnitus on an 11-grade integer Likert scale from 0 to10 points, were used as additional instruments to assess tinnitus severity and distress. Methods: The subjects were healthy adults, and patients with subjective tinnitus who were examined at the Otolaryngology Department of Keio University Hospital, Osaka City University Hospital, or Nagoya City University Hospital with a chief complaint of tinnitus between September 2010 and January 2011. In all, 38 healthy adult subjects and 113 patients with subjective tinnitus were included. We examined the reproducibility and the internal consistency for reliability. We also examined the relationship with the available scales (THI and Hospital Anxiety and Depression Scale, HADS) and group divergence for validity. Results: The psychometric validation showed high reliability and validity of the THI-12, TRS, TRSw, TSS, and TSSw.
Japanese Journal of Clinical Oncology | 2017
Takuma Matoba; Kei Ijichi; T. Yanagi; Kayoko Kabaya; Daisuke Kawakita; Shintaro Beppu; Junichi Torii; Shingo Murakami
Background Induction chemotherapy for patients with head and neck cancer is widely performed, and several advantages of induction chemotherapy have been reported. However, there is currently insufficient evidence to strongly recommend induction chemotherapy. In this study, we analyzed the outcomes for patients treated with induction chemotherapy and subsequent definitive treatments. Methods Operable patients with untreated oropharyngeal, hypopharyngeal and laryngeal squamous cell carcinoma treated with induction chemotherapy were included in this retrospective study. We conducted induction chemotherapy using docetaxel, cisplatin and 5-fluorouracil and performed subsequent surgical treatment or radiotherapy according to the response to induction chemotherapy. Results A total of 65 patients were included in this study, and 50 patients (76.9%) had Stage IV tumors. The response to induction chemotherapy was CR in two patients, PR in 55 patients, and SD in eight patients. The subsequent definitive treatment was radiotherapy in 60 patients, and surgery in five patients. The 3-year overall survival rates for patients who received radiotherapy and surgery were 88.4% and 75.0%, respectively (P = 0.30). The 3-year disease-free survival rates for patients who received radiotherapy and surgery were 68.0% and 0%, respectively (P = 0.01). The 3-year laryngeal dysfunction free survival rates for patients who received RT and surgery were 77.8% and 0%, respectively (P < 0.01). Conclusions We achieved favorable survival outcomes and high larynx preservation rates. Our results suggest that induction chemotherapy using TPF regimen is one of the optimal treatment strategies when treating head and neck cancers. Further prospective studies with a larger cohort are required to confirm our findings.
Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine | 2015
Meiho Nakayama; Ayako Masuda; Kayoko Bhardwaj Ando; Sachie Arima; Kayoko Kabaya; Akira Inagaki; Yoshihisa Nakamura; Motohiko Suzuki; Hilary A. Brodie; Rodney C. Diaz; Shingo Murakami
Equilibrium Research | 2008
Takayasu Asada; Motoyuki Hashiba; Futoshi Matsuda; Nobuhiro Watanabe; Mariko Takahashi; Kayoko Kabaya; Seri Nagai; Shingo Murakami
Auris Nasus Larynx | 2018
Hiroyuki Morimoto; Yuji Asai; Eric G. Johnson; Yoshinori Koide; Junichi Niki; Shigeki Sakai; Meiho Nakayama; Kayoko Kabaya; Ayako Fukui; Yoko Mizutani; Takehiko Mizutani; Yoshino Ueki; Jun Mizutani; Takatoshi Ueki; Ikuo Wada
Equilibrium Research | 2017
Hiroyuki Morimoto; Yuji Asai; Junichi Niki; Yoko Mizutani; Ayako Fukui; Kayoko Kabaya; Meiho Nakayama; Shingo Murakami
Auris Nasus Larynx | 2017
Mariko Takahashi; Kayoko Kabaya; Kenichi Sekiya; Futoshi Matsuda; Yoshimasa Sekiya; Shinichi Esaki; Yuji Sato; Akira Inagaki; Shingo Murakami
Equilibrium Research | 2014
Ryozo Wakabayashi; Hiroyuki Morimoto; Yuji Asai; Yoko Mizutani; Kayoko Kabaya; Keiji Takemura; Motoyuki Hashiba; Nobuhiro Watanabe; Meiho Nakayama; Shingo Murakami